Donepezil in the treatment of agitation in Alzheimer's disease
Background: Agitation is a common and distressing symptom in patients with Alzheimer's disease. Cholinesterase inhibitors improve cognitive outcomes in such patients, but the benefits of these drugs for behavioral disturbances are unclear. Methods: We randomly assigned 272 patients with Alzhei...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2007-10.
|
| Subjects: | |
| Online Access: | Get fulltext |